ArticleInfectious diseases and therapy2022

No Statistically Apparent Difference in Antifungal Effectiveness Observed Among Trimethoprim/Sulfamethoxazole Plus Clindamycin or Caspofungin, and Trimethoprim/Sulfamethoxazole Monotherapy in HIV-Infected Patients with Moderate to Severe Pneumocystis Pneumonia: Results of an Observational Multicenter Cohort Study.

Yinqiu Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.